SWX:ROG.S

Roche share price set for Monday test after MS drug fenebrutinib data lands

Roche said its experimental MS drug fenebrutinib met the main goal in a late-stage study for primary progressive multiple sclerosis, showing “non-inferiority” to Ocrevus but with more frequent, reversible liver enzyme elevations and a higher share of fatal cases. Roche shares last closed down 0.6% at 356.40 francs. Investors await Monday’s webcast for more data and filing plans.

8 February 2026

Biotechnology·Healthcare News·Pharmaceuticals·Stock Market·SWX:ROG.S

Roche stock price in focus: Goldman flips to neutral as ROG heads into Jan. 29 results

Roche shares closed up 0.93% at 348.90 francs Friday after Goldman Sachs raised its rating to neutral and boosted its price target to 365 francs, citing lower-risk clinical catalysts in 2026. UBS lifted its target to 384 francs, while Deutsche Bank held at 325. The SMI fell 0.5%. Swiss markets reopen Monday.

17 January 2026

Earnings Reports·Pharmaceuticals·Stock Market·SWX:ROG.S

Roche stock in focus after MediLink cancer-drug deal as investors eye Jan. 29 results

Roche shares closed up 0.4% at 340.80 Swiss francs after MediLink announced a $570 million licensing deal for cancer drug YL201, granting Roche ex-China rights. The agreement includes additional milestone payments and royalties. Investors are watching Roche’s Jan. 12 conference and Jan. 29 earnings for further details.

10 January 2026

Pharmaceuticals·Stock Market·SWX:ROG.S

Oil Prices Climb on Renewed U.S.-Iran Airstrikes, U.S. Stock Futures Rise
June 28, 2026, 8:36 PM EDT. Oil prices increased on Sunday as the U.S. and Iran exchanged airstrikes in the Persian Gulf, raising concerns over potential disruptions to the Strait of Hormuz, a crucial shipping route. U.S. stock-index futures edged higher amid escalating geopolitical tensions. The developments put energy markets on alert due to possible supply constraints from the strategic waterway.

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026

July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026

IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.

AbbVie stock run lifts pricing on $10.9 billion Apogee deal to six times cost

29 June 2026

AbbVie surged 17% since June 18 to a record $253.35, adding $65 billion in market value—six times its $10.9 billion Apogee buyout—driven by investor demand for long-term immunology growth despite near-term EPS dilution, as Skyrizi won expanded FDA approval and Humira sales fell.

Cisco stock selloff: Friday volume drives 90% of weekly drop before short U.S. market week

29 June 2026

Cisco plunged 4.37% to $113.77 on Friday, erasing $21 billion in market value on volume 2.3 times the recent average, as the stock tracked AI-linked peers instead of the Dow despite strong Q3 results and raised AI order targets; Friday’s close is the live reference for holders ahead of the July 4 holiday-shortened week.

SWX:ROG.S 10 January 2026 - 8 February 2026

Roche share price set for Monday test after MS drug fenebrutinib data lands

Roche stock price in focus: Goldman flips to neutral as ROG heads into Jan. 29 results

Roche stock in focus after MediLink cancer-drug deal as investors eye Jan. 29 results

Stock Market Today

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

AbbVie stock run lifts pricing on $10.9 billion Apogee deal to six times cost

Cisco stock selloff: Friday volume drives 90% of weekly drop before short U.S. market week

Latest Video